Aeterna Zentaris Inc. Shares Close the Day 10.9% Higher - Daily Wrap
The company saw its shares close the day 10.9% higher than yesterday, with trading volume higher than its 30 day average.
Jan 04, 2022 by Kwhen Finance Editors
Aeterna Zentaris Inc. (AEZS) shares closed today 10.9% higher than it did at the end of yesterday. The stock is currently up 10.9% year-to-date, down 7.4% over the past 12 months, and down 88.7% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.6%.
Trading Activity
- Shares traded as high as $0.40 and as low as $0.35 this week.
- Shares closed 89.1% below its 52-week high and 12.5% above its 52-week low.
- Trading volume this week was 34.0% higher than the 10-day average and 141.7% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.9.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Aeterna Zentaris Inc. | 10.9 | 10.9 | -7.4 | ||
| Dow Jones Industrial Average | 0.6 | 0.6 | 21.6 | -0.6 | 24.0 |
| S&P 500 Index | 0.6 | 0.6 | 29.5 | -0.5 | 31.2 |
| Health Care | -0.9 | -0.9 | 22.3 | -0.8 | 27.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by 142.9%
- The company's stock price performance over the past 12 months beats the peer average by -13.1%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Aeterna Zentaris Inc. | AEZS | 0 | 10.9 | -7.4 | ||
| Peer Avg | N/A | 5.6 | 4.5 | -8.5 | -7.9 | 8.8 |
| Novartis AG - ADR | NVS | 37.1 | 0.5 | -3.2 | -8.0 | 10.3 |
| Bristol-Myers Squibb Co. | BMY | -25.6 | 0 | 2.9 | -10.4 | 16.5 |
| Sanofi - ADR | SNY | 8.5 | 1.2 | 8.3 | ||
| Halozyme Therapeutics Inc. | HALO | 13.8 | 0 | -5.9 | -29.0 | 25.9 |
| Spectrum Pharmaceuticals, Inc. | SPPI | 0 | 25.2 | -53.4 | ||
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: